Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. announced today that the latest data confirming the pharmacological effect of lecanemab (generic name, U.S. brand name: ...
Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: ...
After fans went wild over the news of six Edible Mascots at this year's Pop-Tarts™ Bowl, dubbed The People's National ...
BioMedWire: Chronic conditions and rare diseases in the aging population present an urgent and expanding challenge within the U.S. healthcare system, especially as more than 30 million Americans are ...
Students applying to college know they can’t — or at least shouldn’t — use AI chatbots to write their essays and personal statements. So it might come as a surprise ...
Workers were given no forewarning, arriving at work to be told they would be made redundant, effective immediately.